Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07616752
NA

The Impact of Salmon Protein Hydrolysate (SPH / ProGo®) Supplementation on Hematologic and Metabolic Health

Sponsor: Hofseth Biocare ASA

View on ClinicalTrials.gov

Summary

Healthy, overweight males and females randomised to receive 8-weeks of salmon protein hydrolysate SPH (12g daily) or whey protein isolate (12g daily) to assess the impact on red blood cell and ferritin levels, blood glucose levels, BMI, percent body fat and lean body mass along with hair, skin and nail health and blood biomarkers of inflammation.

Official title: A Randomized, Placebo-controlled, Double Blind Study to Evaluate the Impact of ProGo® Supplementation on Hematologic and Metabolic Health Markers in Healthy Adults

Key Details

Gender

All

Age Range

25 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

14

Start Date

2019-07-19

Completion Date

2020-01-03

Last Updated

2026-06-01

Healthy Volunteers

Yes

Interventions

OTHER

Nutritional supplementation

ProGo is a proprietary mix of bioactive peptides.

OTHER

Nutritional Supplement

Standard whey protein

Locations (1)

Spectrum Clinical Research

Mumbai, Maharashtra, India